DESIREE DAVIS: Open Payments
NPI 1215493572 · VANCEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 16 payments from 6 companies in 2025. Trend: 2023 $95 · 2024 $224 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $144 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Amgen Inc. | 1 | $21 |
Products named: Ozempic, Kerendia, TRELEGY ELLIPTA, JARDIANCE, FARXIGA, REPATHA, BREZTRI, Rybelsus.
Industry payments across NC — which companies pay providers there.
